Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D

Journal of Cellular Biochemistry

Volumn 73, Issue 3, 1999, Pages 370-378

  Démoz, Marina ^a   Castino, Roberta ^a   Dragonetti, Antonella ^a   Raiteri, Elisabetta ^a   Baccino, Francesco M ^b,c   Isidoro, Ciro ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CNR   (Italy)

Author keywords

c Ha ras; Cathepsin D; Lysosomes

Indexed keywords

AMMONIUM CHLORIDE; CATHEPSIN D; PROTEIN P21; PROTEINASE;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; ENDOSOME; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; NONHUMAN; ONCOGENE RAS; PH; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT;

EID: 0345280022     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990601)73:3<370::AID-JCB8>3.3.CO;2-E     Document Type: Article

References (36)

1. Baron R. 1989. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 224:317-324.
2. Barrett AJ. 1977. Cathepsin D and other carboxil proteinases. In: Barret AJ, editor. Proteinases in mammalian cells and tissue. North Holland: Amsterdam Bioch. Press, p 209-248.
3. Berg T, Giöen T, Bakke O. 1995. Physiological functions of endosomal proteolysis. Biochem J 307:313-326.
4. Bonelli G, Kay J, Tessitore L, Jupp AR, Isidoro C, Norey CG, Autelli R, Richards AD, Baccino FM. 1988. Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130. Biol Chem Hoppe-Seyler 369: 323-327.
5. Capon DJ, Seeburg PH, McGrath JP, Mayflick JS, Edman V, Levinson AD, Goeddel DV. 1983. Activation of Ki-ras 2 gene in human colon and lung carcinomas by two different points mutations. Nature 304:507-513.
6. Chambers AF, Colella R, Denhardt DT, Wilson SM. 1992. Increased expression of cathepsin L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol Care 5:238-245.
7. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. 1996. Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/Apo-1 and TNF-α. Embo J 15:3861-3870.
8. Denhardt DT. 1996. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling. Biochem J 318:729-747.
9. De Stefanis D, Demoz M, Dragonetti A, Houri JJ, Denis EO, Codogno P, Baccino FM, Isidoro C. 1997. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line. Cell Tissue Res 289:109-117.
10. Dingle JT, Barrett AJ, Weston PP. 1971. Cathepsin D: Characteristic of immunoinhibition and the confirmation of a role in cartilagine breakdown. Biochem J 123:1-8.
11. Fujita H, Tanaka Y, Noguchi Y, Kono A, Himeno M, Kato K. 1991. Isolation and sequencing of a cDNA clone encoding rat liver lysosomal cathepsin D and structure of three forms of mature enzymes. Biochem Biophys Res Comm 179:190-196.
12. Garbisa S, Pozzati R, Muschell RJ, Saffotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA. 1987. Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad 2-E1a. Cancer Res 47:1523-1528.
13. Graham RA, Richardson CL, Minder MD, Trent JM, Buick RN. 1985. Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7. Cancer Res 45:2201-2206.
14. Hasilik A. 1992. The early and late processing of lysosomal enzymes: Proteolysis and compartmentation. Experientia 48:130-151.
15. Hill SA, Wilson S, Chambers AF. 1988. Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ros-transformed NIH 3T3 cells. J Natl Cancer Inst 80:484-490.
16. Horst M, Hasilik A. 1991. Expression and maturation of human cathepsin D in baby hamster kidney cells. Biochem J 273:355-361.
17. Isidoro C, Demoz M, De Stefanis D, Mainferme F, Wattiaux R, Baccino FM. 1995a. Altered intracellular processing and enhanced secretion of procathepsin D in highly deviated rat hepatoma. Int J Cancer 60:61-64.
18. Isidoro C, Demoz M, De Stefanis D, Baccino FM, Bonelli G. 1995b. Synthesis, maturation and extracellular release of procathepsin D as influenced by cell proliferation or transformation. Int J Cancer 63:866-871.
19. Isidoro C, Baccino FM, Hasilik A. 1997a. Mis-sorting of procathepsin D in metastogenic tumor cell is not due to impaired synthesis of the phosphomannosyl signal. Int J Cancer 70:561-566.
20. Isidoro C, Demoz M, De Stefanis D, Baccino FM, Hasilik A, Bonelli G. 1997b. Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts. Int J Cancer 70:310-314.
21. Isidoro C, De Stefanis D, Demoz M, Ogier-Denis E, Codogno P, Baccino FM. 1997c. Expression and posttranslational fate of Cathepsin D in HT-29 tumor cells depend on their enterocytic differentiation state. Cell Growth Diff 8:1029-1037.
22. Jang WL, Maher VM, McCormick JJ, Schindler M. 1990. Alkalinization of the lysosomes is correlated with ras transformation of murine and human fibroblasts. J Biol Chem 265:4775-4777.
23. Liaudet E, Garcia M, Rochefort H. 1994. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. Oncogene 9:1145-1154.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
25. Lowy DR, Willumsen BM. 1993. Function and regulation of ras. Annu Rev Biochem 62:851-891.
26. Ludwig T, Griffiths G, Hoflack B. 1991. Distribution of newly synthesized lysosomal enzymes in the endocytic pathway of normal rat kidney cells. J Cell Biol 115:1561-1572.
27. Machesky LM, Hall A. 1996. Rho: A connection between membrane receptor signalling and the cytoskeleton. Trends Cell Biol 6:304-312.
28. Marshall CJ. 1991. How does p21 ras transform cells? Trends Cell Biol 7:91-95.
29. Muschel RJ, Williams JE, Lowy DR, Liotta LA. 1985. Harvey ras induction of metastasis potential depends upon oncogene activation and type of recipient cell. Am J Pathol 121:1-8.
30. Ochieng J, Basolo F, Albini A, Melchiori A, Watanabe H, Elliott J, Raz A, Parodi S, Russe J. 1991. Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metast 11:38-47.
31. Pozzati R, Muschel R, Williams J, Padmanabhan R, Howard B, Liotta L, Khoury G. 1986. Primary rat embryo cells transformed by one or two oncogene show different metastatic potentials. Science 232:223-227.
32. Press B, Feng Y, Hoflack B, Wandinger-Ness A. 1990. Mutant Rab7 causes accumulation of Cathepsin D and cation-independent mannose 6-phosphate receptor in an early endocytic compartment. J Cell Biol 5:1075-1089.
33. Rochefort H. 1990. Biological and clinical significance of cathepsin D in breast cancer. Semin Cancer Biol 1:153-160.
34. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, Von Figura K, Peters L. 1995. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. Embo J 14:3599-3608.
35. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. 1994. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci 107:373-384.
36. Tabin CJ, Bradley SM, Borgmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH. 1982. Mechanism of activation of a human oncogene. Nature 300:143-149.